Thermo Fisher Scientific (TMO) Other Non-Current Liabilities (2009 - 2026)

Thermo Fisher Scientific has reported Other Non-Current Liabilities for 18 years, with the latest figure at $4.5 billion in Q2 2026.

• Other Non-Current Liabilities for Q2 2026 came in at $4.5 billion, up 6.28% year-over-year; the trailing twelve-month figure through Jun 2026 was $4.5 billion (up 6.28% YoY), and the FY2025 annual result was $4.3 billion, up 7.12% from the prior year.
• Other Non-Current Liabilities climbed to $4.5 billion in Q2 2026, from $4.4 billion in the prior quarter.
• Over five years, Other Non-Current Liabilities peaked at $4.7 billion in Q2 2022 and troughed at $4.0 billion in Q1 2025.
• A 5-year average of $4.3 billion and a median of $4.3 billion in 2023 frame the typical range for Other Non-Current Liabilities.
• The widest annual swing landed in 2022, when Other Non-Current Liabilities surged 39.14%; it then slipped 14.07% in 2024.
• A 5-year view of Other Non-Current Liabilities shows it stood at $4.2 billion in 2022, then climbed by 9.53% to $4.6 billion in 2023, then decreased by 14.07% to $4.0 billion in 2024, then increased by 7.12% to $4.3 billion in 2025, then advanced by 6.2% to $4.5 billion in 2026.
• Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $4.5 billion in Q2 2026, $4.4 billion in Q1 2026, and $4.3 billion in Q4 2025.